ACET
Price
$0.94
Change
+$0.02 (+2.17%)
Updated
Jan 23, 04:59 PM (EDT)
Capitalization
77.74M
48 days until earnings call
ONCY
Price
$0.81
Change
-$0.07 (-7.95%)
Updated
Jan 23, 04:59 PM (EDT)
Capitalization
62.64M
42 days until earnings call
Ad is loading...

ACET vs ONCY

Header iconACET vs ONCY Comparison
Open Charts ACET vs ONCYBanner chart's image
Adicet Bio
Price$0.94
Change+$0.02 (+2.17%)
Volume$300
Capitalization77.74M
Oncolytics Biotech
Price$0.81
Change-$0.07 (-7.95%)
Volume$11.33K
Capitalization62.64M
ACET vs ONCY Comparison Chart
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. ONCY commentary
Jan 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Buy and ONCY is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 24, 2025
Stock price -- (ACET: $0.92 vs. ONCY: $0.88)
Brand notoriety: ACET and ONCY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACET: 23% vs. ONCY: 239%
Market capitalization -- ACET: $77.74M vs. ONCY: $62.64M
ACET [@Biotechnology] is valued at $77.74M. ONCY’s [@Biotechnology] market capitalization is $62.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $360.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 2 FA rating(s) are green whileONCY’s FA Score has 0 green FA rating(s).

  • ACET’s FA Score: 2 green, 3 red.
  • ONCY’s FA Score: 0 green, 5 red.
According to our system of comparison, ACET is a better buy in the long-term than ONCY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 3 TA indicator(s) are bullish while ONCY’s TA Score has 1 bullish TA indicator(s).

  • ACET’s TA Score: 3 bullish, 5 bearish.
  • ONCY’s TA Score: 1 bullish, 5 bearish.
According to our system of comparison, ACET is a better buy in the short-term than ONCY.

Price Growth

ACET (@Biotechnology) experienced а -1.28% price change this week, while ONCY (@Biotechnology) price change was +7.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.92%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was -1.05%.

Reported Earning Dates

ACET is expected to report earnings on May 20, 2025.

ONCY is expected to report earnings on May 02, 2025.

Industries' Descriptions

@Biotechnology (+3.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACET($77.7M) has a higher market cap than ONCY($62.6M). ONCY YTD gains are higher at: -3.699 vs. ACET (-4.574). ONCY has higher annual earnings (EBITDA): -34.96M vs. ACET (-111.35M). ACET has more cash in the bank: 202M vs. ONCY (19.6M). ONCY has less debt than ACET: ONCY (1.06M) vs ACET (18.2M). ACET (0) and ONCY (0) have equivalent revenues.
ACETONCYACET / ONCY
Capitalization77.7M62.6M124%
EBITDA-111.35M-34.96M318%
Gain YTD-4.574-3.699124%
P/E RatioN/AN/A-
Revenue00-
Total Cash202M19.6M1,031%
Total Debt18.2M1.06M1,711%
FUNDAMENTALS RATINGS
ACET vs ONCY: Fundamental Ratings
ACET
ONCY
OUTLOOK RATING
1..100
1033
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
68
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
6564
P/E GROWTH RATING
1..100
22100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (33) in the Medical Distributors industry is somewhat better than the same rating for ONCY (68) in the Biotechnology industry. This means that ACET’s stock grew somewhat faster than ONCY’s over the last 12 months.

ACET's Profit vs Risk Rating (100) in the Medical Distributors industry is in the same range as ONCY (100) in the Biotechnology industry. This means that ACET’s stock grew similarly to ONCY’s over the last 12 months.

ACET's SMR Rating (97) in the Medical Distributors industry is in the same range as ONCY (99) in the Biotechnology industry. This means that ACET’s stock grew similarly to ONCY’s over the last 12 months.

ONCY's Price Growth Rating (64) in the Biotechnology industry is in the same range as ACET (65) in the Medical Distributors industry. This means that ONCY’s stock grew similarly to ACET’s over the last 12 months.

ACET's P/E Growth Rating (22) in the Medical Distributors industry is significantly better than the same rating for ONCY (100) in the Biotechnology industry. This means that ACET’s stock grew significantly faster than ONCY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETONCY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 16 days ago
84%
Bearish Trend 16 days ago
87%
Momentum
ODDS (%)
Bullish Trend 16 days ago
84%
Bearish Trend 16 days ago
85%
MACD
ODDS (%)
Bullish Trend 16 days ago
76%
N/A
TrendWeek
ODDS (%)
Bearish Trend 16 days ago
86%
Bearish Trend 16 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 16 days ago
90%
Bullish Trend 16 days ago
75%
Advances
ODDS (%)
Bullish Trend 18 days ago
82%
Bullish Trend 21 days ago
79%
Declines
ODDS (%)
Bearish Trend 16 days ago
88%
Bearish Trend 16 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 16 days ago
90%
Aroon
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 16 days ago
85%
View a ticker or compare two or three
Ad is loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGRM2.850.17
+6.34%
Monogram Orthopaedics
NABL9.540.10
+1.06%
N-able
AMGN273.44-1.37
-0.50%
Amgen
NBN101.05-0.84
-0.82%
Northeast Bank
MUR30.86-0.63
-2.00%
Murphy Oil Corp

ONCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONCY has been loosely correlated with SRRK. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ONCY jumps, then SRRK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONCY
1D Price
Change %
ONCY100%
+5.26%
SRRK - ONCY
36%
Loosely correlated
+4.12%
VCYT - ONCY
27%
Poorly correlated
-1.26%
ABCL - ONCY
26%
Poorly correlated
+15.36%
FULC - ONCY
26%
Poorly correlated
+2.25%
ACET - ONCY
26%
Poorly correlated
-2.23%
More